JM
Jeffrey Mosebrook
SVP, Fin & Princ Acct Officer

Jeffrey Mosebrook insider trades: Integra Lifesciences Holdings (IART) stock sales

SVP, Fin & Princ Acct Officer, Integra Lifesciences Holdings Last trade Aug 19, 2024 35 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2017
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 19, 2024IART↓ Sell$26K
Aug 9, 2023IART↓ Sell$52K
Dec 8, 2022IART↓ Sell$16K
Aug 2, 2022IART↓ Sell$25K
Nov 10, 2021IART↓ Sell$50K
Mar 2, 2021IART↓ Sell$73K
Aug 13, 2020IART↓ Sell$42K
Jul 30, 2019IART↓ Sell$75K
Aug 10, 2018IART↓ Sell$62K
Nov 20, 2017IART↓ Sell$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey Mosebrook's insider trades

Jeffrey Mosebrook is SVP, Fin & Princ Acct Officer at Integra Lifesciences Holdings (IART). Since Nov 20, 2017, Jeffrey has reported no open-market purchases and 10 sales worth $427K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (17 filings), grants and awards (17 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IART insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.